CFDA qualitative! These two kinds of ginkgo leaf products are fake medicines!

Since May this year, there has been a new development in the ginkgo drug crisis The State Food and Drug Administration recently issued the notice of the State Food and Drug Administration on the punishment of illegal production and sale of Ginkgo biloba extract and preparations, in which the quality of fake Ginkgo biloba and substandard drugs was determined According to the announcement, according to the supplementary inspection method for Sophoricoside inspection items (approval No.: 2015007), Ginkgo biloba extract and preparations with positive Sophoricoside were detected, and they were identified as fake drugs according to the provisions of item 1, paragraph 2, Article 48 of the drug administration law In addition, according to the supplementary inspection method for free quercetin, kaempferol and isorhamnetin (approval document No.: 2015001-2015006), Ginkgo biloba extract and preparations whose free quercetin, kaempferol and isorhamnetin inspection items do not meet the requirements shall be punished as inferior drugs according to Article 49, paragraph 3 (6) of the drug administration law This started from the wave of illegal production and sale of Ginkgo biloba drugs by enterprises such as Guilin Xingda Pharmaceutical Co., Ltd which once spread to famous enterprises such as Yunnan Baiyao and Kangenbei In May alone, CFDA issued four documents in succession, bringing all Ginkgo biloba extract production enterprises into the scope of supervision, and the scope of recall was expanding Related reading: it's half a year since the inventory of enterprises involved in the ginkgo leaf drug storm, and the announcement once again set off the regulatory climax of the ginkgo leaf drug storm According to the announcement, the illegal behaviors of Ginkgo biloba extract production enterprises, such as violating drug standards, adulterating and changing process, are the source of producing fake drugs and inferior drugs for Ginkgo biloba preparation enterprises, which have obvious subjective intention and impose severe punishment on Ginkgo biloba extract production enterprises and relevant responsible personnel according to law; those suspected of crimes shall be transferred to public security organs for punishment according to law Responsibility If a pharmaceutical production and marketing enterprise knows that Ginkgo biloba extract is still used or sold as an illegal product, resulting in the determination of the Ginkgo biloba preparation as fake or substandard, it shall be severely punished according to law for the pharmaceutical production and marketing enterprise and the relevant responsible personnel; if it is suspected of a crime, it shall be transferred to the public security organ for criminal responsibility according to law However, those who refuse or evade supervision and inspection, or forge records, forge samples, destroy or conceal relevant evidence materials shall be given heavier punishment according to law.